Psychedelic Invest’s Charley Rose sat down with the CEO of Kernel, Ryan Field.

During the interview, Charley does a deep dive into the company’s work building next-generation neuroimaging technology and how it could help advance the field of psychedelic science. Ryan Field offers a fascinating look at how a portable neuroimaging device could be used to propel our understanding of the human brain forward.

Learn More on Our YouTube channel

If you’d like to watch more interviews like this one, head over to our YouTube channel and like and subscribe. We release regular content as we continue to provide analyses and insights on the psychedelics market and industry as a whole.